Drug interactions
Glimepiride-pioglitazone + Methyl aminolevulinate
Severity: Minor
Glimepiride-pioglitazone and Methyl aminolevulinate: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Glimepiride and pioglitazone may cause photosensitivity, and methyl aminolevulinate is a topical photosensitizer. Additive phototoxicity is theoretical, and systemic exposure to the topical product is minimal.
What this interaction means in plain words
Glimepiride-pioglitazone and Methyl aminolevulinate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Why it happens
Additive photosensitizing effects, with minimal systemic absorption of the topical agent.
What to do
Counsel patients on protecting the treated area from light. No change in antidiabetic therapy is required.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Glimepiride-pioglitazone and Methyl aminolevulinate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Glimepiride-pioglitazone
Frequently asked questions
Can I take Glimepiride-pioglitazone with Methyl aminolevulinate?
MediHelp rates the interaction as minor. Glimepiride-pioglitazone and Methyl aminolevulinate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Glimepiride and pioglitazone may cause photosensitivity, and methyl aminolevulinate is a topical photosensitizer. Additive phototoxicity is theoretical, and systemic exposure to the topical product is minimal.
How serious is the interaction between Glimepiride-pioglitazone and Methyl aminolevulinate?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Counsel patients on protecting the treated area from light. No change in antidiabetic therapy is required.
What other medicines interact with Glimepiride-pioglitazone?
MediHelp also lists interactions of Glimepiride-pioglitazone with, for example, Fluconazole, Gemfibrozil, Insulin aspart. The full list is on the Glimepiride-pioglitazone page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
